Endurant Capital Management’s Globus Medical GMED Stock Holding History

Endurant Capital Management’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-65,700	Closed	-$1.56M	–	92
2016 Q1	$1.56M	Buy	65,700 +21,071	+47%	+$515K	0.51%	50
2015 Q4	$1.24M	Sell	44,629 -409,100	-90%	-$10.3M	0.42%	53
2015 Q3	$9.37M	Sell	453,729 -91,110	-17%	-$2.31M	3.13%	10
2015 Q2	$14M	Sell	544,839 -52,014	-9%	-$1.32M	4.13%	5
2015 Q1	$15.1M	Buy	596,853 +386,553	+184%	+$9.42M	4.98%	1
2014 Q4	$5M	Buy	+210,300	New	+$4.66M	1.96%	16

Other funds holding GMED

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

AAM

Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.46% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Endurant Capital Management's GMED Position: Q2 2016 in Review

Endurant Capital Management sold out of Globus Medical (GMED) in Q2 2016, closing a stake of 65,700 shares — an estimated $1.56M sold.

Endurant Capital Management first reported a position in GMED in Q4 2014 and held it in 6 quarters. The position peaked at $15.1M in Q1 2015. 209 funds tracked by Wall St. Rank hold GMED as of Q2 2016.

Endurant Capital Management reported no remaining Globus Medical position as of Q2 2016 after selling out during the quarter.
Endurant Capital Management sold 65,700 Globus Medical shares in Q2 2016, an estimated $1.56M.
Endurant Capital Management first reported a position in Globus Medical in Q4 2014 and held it in 6 quarters.
Endurant Capital Management's Globus Medical position peaked at $15.1M in Q1 2015.
209 funds tracked by Wall St. Rank held Globus Medical as of Q2 2016.

Based on Endurant Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.